Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2111359rdf:typepubmed:Citationlld:pubmed
pubmed-article:2111359lifeskim:mentionsumls-concept:C0262950lld:lifeskim
pubmed-article:2111359lifeskim:mentionsumls-concept:C0024687lld:lifeskim
pubmed-article:2111359lifeskim:mentionsumls-concept:C0007738lld:lifeskim
pubmed-article:2111359lifeskim:mentionsumls-concept:C0205321lld:lifeskim
pubmed-article:2111359lifeskim:mentionsumls-concept:C0699948lld:lifeskim
pubmed-article:2111359pubmed:issue2lld:pubmed
pubmed-article:2111359pubmed:dateCreated1990-6-25lld:pubmed
pubmed-article:2111359pubmed:abstractTextThe concentration of cephradine in serum and mandibular bone was assayed in 28 patients undergoing 3rd molar surgery following a single 1 g intravenous injection. Serum and cortical bone samples taken simultaneously, contained mean cephradine concentrations of 42.11 micrograms/ml and 2.61 micrograms/g respectively. These results, when compared with those reported for other bony sites including the femoral head and knee, show a reduced bone penetration with a bone-to-serum ratio of approximately 0.06:1.lld:pubmed
pubmed-article:2111359pubmed:languageenglld:pubmed
pubmed-article:2111359pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111359pubmed:citationSubsetDlld:pubmed
pubmed-article:2111359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111359pubmed:statusMEDLINElld:pubmed
pubmed-article:2111359pubmed:monthAprlld:pubmed
pubmed-article:2111359pubmed:issn0901-5027lld:pubmed
pubmed-article:2111359pubmed:authorpubmed-author:RoodJ PJPlld:pubmed
pubmed-article:2111359pubmed:authorpubmed-author:MiddlehurstR...lld:pubmed
pubmed-article:2111359pubmed:issnTypePrintlld:pubmed
pubmed-article:2111359pubmed:volume19lld:pubmed
pubmed-article:2111359pubmed:ownerNLMlld:pubmed
pubmed-article:2111359pubmed:authorsCompleteYlld:pubmed
pubmed-article:2111359pubmed:pagination120-1lld:pubmed
pubmed-article:2111359pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:meshHeadingpubmed-meshheading:2111359-...lld:pubmed
pubmed-article:2111359pubmed:year1990lld:pubmed
pubmed-article:2111359pubmed:articleTitleCephradine (Velosef) penetration of mandibular bone.lld:pubmed
pubmed-article:2111359pubmed:affiliationDepartment of Oral and Maxillofacial Surgery, Turner Dental School, University Dental Hospital of Manchester, England.lld:pubmed
pubmed-article:2111359pubmed:publicationTypeJournal Articlelld:pubmed